本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atea Pharmaceuticals, Inc.

5.30
+0.32006.43%
盤後5.21-0.0873-1.65%19:08 EST
成交量:144.21萬
成交額:752.93萬
市值:4.14億
市盈率:-3.00
高:5.34
開:4.99
低:4.98
收:4.98
52周最高:5.34
52周最低:2.46
股本:7,812.68萬
流通股本:6,000.97萬
量比:3.57
換手率:2.40%
股息:- -
股息率:- -
每股收益(TTM):-1.7696
每股收益(LYR):-1.9983
淨資產收益率:-37.98%
總資產收益率:-23.86%
市淨率:1.31
市盈率(LYR):-2.65

資料載入中...

公司資料

公司名字:
Atea Pharmaceuticals, Inc.
交易所:
NASDAQ
成立時間:
2012
員工人數:
56
公司地址:
225 Franklin Street,Suite 2100,Boston,Massachusetts,United States
郵編:
02110
電話:
傳真:
- -
簡介:
Atea Pharmaceuticals, Inc.於2012年7月註冊成立,並於2014年3月開始主要運營。該公司是一家臨床階段的生物製藥公司,利用對抗病毒藥物開發、藥物化學、生物學、生物化學和病毒學的深刻理解,發現和開發新型口服候選產品,以治療嚴重的病毒性疾病。

董事

名稱
職位
Jean Pierre Sommadossi
President,Chief Executive Officer and Chairman of the Board
Arthur Kirsch
Independent Director
Barbara Duncan
Independent Director
Bruce Polsky
Independent Director
Bruno Lucidi
Independent Director
Franklin Berger
Lead Independent Director
Howard Berman
Independent Director
Jerome Adams
Independent Director
Polly A. Murphy
Independent Director

股東

名稱
職位
Jean Pierre Sommadossi
President,Chief Executive Officer and Chairman of the Board
Andrea Corcoran
Chief Financial Officer and Executive Vice President, Legal and Secretary
Janet Hammond
Chief Development Officer
John Vavricka
Chief Commercial Officer
Maria Arantxa Horga
Chief Medical Officer
Wayne Foster
Chief Accounting Officer and Executive Vice President